Skip to content

Costs, Cognitive Abilities and Quality of Life After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement

Costs, Cognitive Abilities and Quality of Life After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01852552
Acronym
CCQ
Enrollment
518
Registered
2013-05-13
Start date
2011-12-31
Completion date
2016-01-31
Last updated
2016-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis

Keywords

Aortic stenosis, Transcatheter aortic valve implantation, Aortic valve replacement, Costs, Cognitive function, Quality of life

Brief summary

Multicenter, prospective, observational study in aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVI) or high-risk patients undergoing aortic valve replacement (AVR). The objectives of the study are: 1. Description of neurocognitive status before and after transcatheter aortic valve implantation and aortic valve replacement procedures 2. Description of Quality of Life (QoL) after these procedures 3. Defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities 4. Assessment of costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and costs of follow-up.

Detailed description

In Italy, a nation-wide observational study endorsed by the Superior Institute of Health has been previously launched in order to evaluate appropriateness and effectiveness of aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI) procedures: the OBservational Study of Effectiveness of AVR-TAVI procedures for severe Aortic steNosis Treatment (OBSERVANT). The present study was designed to complement the national survey on TAVI and AVR procedures including data about costs, cognitive functions and quality of life after these procedures. This integrated framework may help defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities and, on the other hand, should enable accurate evaluation of the impact of each kind of treatment on quality of life and neuropsychological functions. These elements could also represent relevant keys to decision-making to the different therapeutic strategies. In addition, we aim to ascertain costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and follow-up costs. Costs estimate, combined to the integrated physical and mental health status outcome for each treatment modality, may represent the background for subsequent cost-effectiveness analyses. All consecutive patients undergoing transcatheter aortic valve implantation or aortic valve replacement (if age ≥ 80 years or Logistic Euroscore ≥ 15%) for aortic stenosis at participating centers during the period of enrollment will be included in the registry, after release of written informed consent. Allocation of patients to different treatment groups will be performed jointly by a cardiologist and a cardiac surgeon on the basis of a complete clinical framework, independently from the present study and in accordance with available guidelines. Type of treatment (for example, access site for TAVI, type of prosthesis…) will be decided by the physicians based on local clinical practice and general principles of good clinical practice. The administration of neurocognitive and quality of life questionnaires will be performed before the procedure and after 3 months and 1 year by trained personnel following standard operation procedures defined by a coordinating unit. A telephone and web-based support for operators will be available throughout the entire duration of the study. A common methodology for data collection and analysis is defined to guarantee data reliability and homogeneity of assessments among the participating units. The cost analysis will be coordinated by the Regional Healthcare and Social Agency of the Emilia Romagna Region. Data will be collected in a web-based database (OBSERVANT) through dedicated Case Records Forms and a final database will be built by merging this database with a separate database for costs and Hospital Discharge Records and Mortality Registry databases.

Interventions

DEVICEtranscatheter aortic valve implantation

Patients undergoing TAVI with transfemoral, transapical, or any other vascular access

PROCEDUREAortic Valve Replacement

Surgical AVR, with all kind of commercially available prosthesis (stented, stentless, mechanical)

Sponsors

Ministry of Health, Italy
CollaboratorOTHER_GOV
Region Emilia-Romagna, Italy
CollaboratorUNKNOWN
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All consecutive patients undergoing TAVI at participating centers during the period of enrollment * All consecutive patients aged ≥80 years or with Logistic Euroscore ≥15% undergoing AVR at participating centers during the period of enrollment

Exclusion criteria

* Absence of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Mini Mental State Examination (MMSE)baseline, 3-month, 12-monthChanges in cognitive function after transcatheter aortic valve implantation and surgical aortic valve replacement
Hospital Anxiety and Depression Scale (HADS)baseline, 3-month, 12-monthChanges of emotional status after transcatheter aortic valve implantation and surgical aortic valve replacement
Minnesota Living with Heart Failure Questionnaire (MLHFQ)baseline, 3-month, 12-monthChanges in quality of life after transcatheter aortic valve implantation and surgical aortic valve replacement
In-hospital costsParticipants will be followed for the duration of hospital stay, an expected average of 10 days for transcatheter aortic valve implantation and 2 weeks for surgical Aortic Valve ReplacementCalculation of precise hospital costs for transcatheter aortic valve implantation and surgical Aortic Valve Replacement, including costs of hospitalization, drugs and devices.

Secondary

MeasureTime frameDescription
Bleedings30-dayIncidence of bleedings as defined by the VARC
Myocardial infarction30-day, 12-month and up to 2-year (longest available follow-up)Incidence of myocardial infarction
Follow-up costs12-monthEvaluation of costs during follow-up, including new hospital admissions, outpatient clinic and drugs
Acute kidney injury30-dayIncidence of AKI as defined by the VARC
Stroke30-day, 12-month and up to 2-year (longest available follow-up)Incidence of stroke
Pace-maker implantation30-day, 12-monthNeed for permanent pacing
Vascular complications30-dayIncidence of vascular complications as defined by the VARC

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026